United States · Series A startup

Who invested in MEND

3 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Raised 11 months ago

Funding summaryUpdated 26 Oct 2026

$27Mraised across 3 rounds since 2015, from 3 sources

$4.3MSeed$2.5MDebt$20MSeries A

Latest round: Series A, $20MDec 2025
Step-upi: 8×
Investors: 3

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20172019202120232025

$4.3MSeed$2.5MDebt$20MSeries A

First round: Seed, $4.3M
Biggest round: $20M
Usual gap between rounds: 8.8 years

The rounds

Dec 2025
Series A$20M2 new
- Alumni Ventures
- S2G Investments
Source recorded
Sept 2024
Debt$2.5M1 new
- Magma Partners
Source recorded
Oct 2015
Seed$4.3M
No investor was named in the report.
From a historical funding record

Founders and team

From MEND's own website: 2 founders, 3 on the team.

Eziah SyedCo-Founder & Chief of Growth & Innovation

Whitney StevensCo-Founder & Senior Strategist

Paul RoscoeCEO
Eden KleinChief Technology Officer
Jaclyn HenkhausGeneral Manager, Mend Well

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Seed2015Debt2024Series A2025

Alumni Ventures

S2G Investments

Magma Partners

Everyone who backed them

Alumni VenturesVC firm1round

S2G InvestmentsGrowth equity1round

Magma PartnersVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 3 firms list MEND as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.